Close Menu
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Facebook X (Twitter) Instagram
Facebook LinkedIn
Financial Market News
Subscribe Now
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Financial Market News
You are at:Home»Posts Tagged "GSK plc"

Trump tariffs fall, but trade war impacts linger

By FinMar NewsApril 3, 2026

A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave of economic and political uncertainty, some…

Trump health care plan likely good for pharmaceutical companies

By FinMar NewsJanuary 26, 2025

U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November…

Medicare drug price negotiations list includes Ozempic

By FinMar NewsJanuary 18, 2025

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo,…

Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS

By FinMar NewsNovember 15, 2024

Robert F. Kennedy Jr. in Phoenix on Aug. 23, 2024.Thomas Machowicz | ReutersShares of vaccine makers fell Thursday as President-elect Donald Trump nominated Robert F. Kennedy…

Merck says experimental RSV treatment protected infants in trial

By FinMar NewsOctober 18, 2024

The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021.Andrew Kelly | ReutersMerck on Thursday said its…

FDA approves Merck pneumococcal disease vaccine designed for adults

By FinMar NewsJune 17, 2024

Zoom In IconArrows pointing outwardsMerck’s new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck’s new vaccine designed to protect adults from a…

FDA approves GSK RSV vaccine for adults 50 to 59

By FinMar NewsJune 7, 2024

A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.Hannah Mckay | ReutersThe Food and Drug Administration on Friday expanded the approval of GSK’s respiratory…

FDA approves Moderna RSV vaccine for seniors

By FinMar NewsJune 2, 2024

The FDA has approved Moderna’s RSV vaccine for older adults.Courtesy: ModernaThe Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults…

FTC challenges patents held by drugmakers, including for Ozempic

By FinMar NewsApril 30, 2024

A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | ReutersThe Federal Trade Commission on Tuesday…

Energy News

Hegseth says ‘the ceasefire is not over’ after U.S., Iran exchange fire

Reform government could cause Truss-style chaos, says renewables industry |

Oil rises as U.S. launches to open Strait of Hormuz

Industry and Policy Leaders Gather for North American Environment, Energy &

Banks News

The investment banking AI push is a rising tide

AUSTRAC warns of growing insider threat in banking amid mortgage fraud

Korea Eximbank forges strategic partnership with Uzbek ministry

March Loan Growth Indicates Banking Sector Resiliency

Real Estate News

NAI Ruhl Commercial Company releases Quad Cities commercial real estate

Protesters picket Manhattan synagogue over Israel real estate sale – The

Property reappraisal ‘moratorium’ poised for vote in NC Senate :: WRAL.com

HL Real Estate Network and 5W Release The 10-Year Loss Index, Ranking the

© 2026 finmar.news

Type above and press Enter to search. Press Esc to cancel.

Social Media Auto Publish Powered By : XYZScripts.com